Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¸¶À̺½»ù±â´ÉÀúÇÏÁõÀ» ¼ö¹ÝÇÏ´Â ¿°Áõ¼º °Ç¼º¾È °¨º°À» À§ÇÑ ¡®TNF-¥á, IL-6, MMP-9¡¯ °Ë»çÅ°Æ®ÀÇ À¯¿ë¼º Æò°¡ Evaluation of ¡®TNF-¥á, IL-6, and MMP-9¡¯ Test Kit for Screening of Meibomian Dysfunction in Patients with Inflammatory Dry Eye Syndrome

´ëÇѽðúÇÐȸÁö 2020³â 22±Ç 1È£ p.29 ~ 39
¹Ú¹ÎÇý, ¹ÚÁ¤Àº, º¯Àå¿ø, ÃÖ¹ÎÁö, Á¶ÀÏÈÆ, Á¤¸íÁø, ÃÖÀ±Á¤, À̱ºÀÚ,
¼Ò¼Ó »ó¼¼Á¤º¸
¹Ú¹ÎÇý ( Park Min-Hye ) 
À»Áö´ëÇб³ ÀϹݴëÇпø ¾È°æ±¤Çаú

¹ÚÁ¤Àº ( Park Jung-Eun ) 
À»Áö´ëÇб³ ÀϹݴëÇпø ¾È°æ±¤Çаú
º¯Àå¿ø ( Byun Jang-Won ) 
°ø¾È°úÀÇ¿ø
ÃÖ¹ÎÁö ( Choi Min-Ji ) 
À»Áö´ëÇб³ ÀϹݴëÇпø ½Ã´Ï¾îÇコÄɾîÇаú
Á¶ÀÏÈÆ ( Cho Il-Hoon ) 
À»Áö´ëÇб³ ÀÓ»óº´¸®Çаú
Á¤¸íÁø ( Jeong Myeong-Jin ) 
À»Áö´ëÇб³ º¸°Çȯ°æ¾ÈÀüÇаú
ÃÖÀ±Á¤ ( Choy Yoon-Jung ) 
À»Áö´ëÇб³ ¾È°æ±¤Çаú
À̱ºÀÚ ( Lee Koon-Ja ) 
À»Áö´ëÇб³ ¾È°æ±¤Çаú

Abstract

¸ñÀû : ¸¶À̺½»ù±â´ÉÀúÇÏÁõ(meibomian gland dysfunction, MGD)À» ¼ö¹ÝÇÏ´Â ¿°Áõ¼º °Ç¼º¾ÈÀÇ °¨º°Áø´Ü¿¡ ´ëÇÑ ¡®TNF-¥á, IL-6, MMP-9¡¯ °Ë»çÅ°Æ®ÀÇ À¯¿ë¼ºÀ» Æò°¡ÇÏ¿´´Ù.

¹æ¹ý : °Ç¼º¾È ÀÌ¿ÜÀÇ ¾ÈÁúȯÀÌ ¾ø´Â 20~30´ë Áß OSDI ¼³¹® °Ë»ç¿¡ µû¸¥ °Ç¼º¾È ÃÑ 118¾ÈÀ» ´ë»óÇÏ¿´°í, °á¸·³¶ ¸Þ´Ï½ºÄ¿½º·ÎºÎÅÍ ¼Ò·®ÀÇ ´«¹°À» äÃëÇÏ¿© TNF-¥á, IL-6 ¹× MMP-9 °Ë»ç¸¦ ÇÏ¿´´Ù. °¢¸·¿°»ö°ú °á¸·ÃæÇ÷ÀÌ ¸ðµÎ Grade 1 ÀÌ»óÀÎ °æ¿ì´Â ¿°Áõ¼º °Ç¼º¾ÈÀ¸·Î, ¸¶À̺½»ùÆó¼â¿Í ¸¶À̺½»ù±¸¸Û¸·ÈûÀÌ ¸ðµÎ grade 1 ÀÌ»óÀÎ °æ¿ì´Â MGD °ü·Ã °Ç¼º¾ÈÀ¸·Î Æò°¡ÇÏ¿´´Ù. ¿°Áõ¼º °Ç¼º¾È ¹× MGD¿Í TNF-¥á, IL-6, MMP-9°úÀÇ »ó°ü¼ºÀº Ä«ÀÌÁ¦°ö°ËÁ¤(Chi-square test)À¸·Î ºÐ¼®ÇÏ¿´°í, ¡®TNF-¥á, IL-6, MMP-9¡¯ °Ë»çÅ°Æ®ÀÇ ¿°Áõ¼º °Ç¼º¾È°ú MGD¸¦ ¼ö¹ÝÇÏ´Â ¿°Áõ¼º °Ç¼º¾È °¨º°´É·ÂÀº ROC Ä¿ºê¸¦ ÀÌ¿ëÇÏ¿© ¹Î°¨µµ, ƯÀ̵µ ¹× AUC(Area under the curve)¸¦ ±¸ÇÏ°í Á¤È®µµ¸¦ Æò°¡ÇÏ¿´´Ù.

°á°ú : ¿°Áõ¼º °Ç¼º¾ÈÀº TNF-¥á¿Í IL-6¿Í À¯ÀÇÇÑ »ó°ü¼ºÀ» º¸¿´°í(p£¼.050), ¡®TNF-¥á, IL-6, MMP-9¡¯ °Ë»ç Å°Æ®´Â MMP-9 °Ë»çÅ°Æ®¿Í 80.20%ÀÇ ³ôÀº ÀÏÄ¡µµ¸¦ ³ªÅ¸³ÂÀ¸³ª(p£¼.050), ¿°Áõ¼º °Ç¼º¾È °¨º°¿¡ ´ëÇÑ ¹Î°¨µµ, ƯÀ̵µ, Á¤È®µµ´Â MMP-9 °Ë»çÅ°Æ®º¸´Ù ³·¾Ò´Ù. MGD´Â MMP-9 °Ë»ç¿Í »ó°ü¼ºÀ» º¸ÀÌÁö ¾Ê¾Ò°í, TNF-¥á¿Í IL-6 °Ë»ç¿Í´Â À¯ÀÇÇÑ »ó°ü¼ºÀ» º¸¿´À¸¸ç, MGD °¨º°¿¡ ´ëÇÑ ¹Î°¨µµ, ƯÀ̵µ, Á¤È®µµ´Â °¢°¢ 85.50%, 34.70%, 0.601, 85.50%, 32.70%, 0.591·Î ³ªÅ¸³µ´Ù. MGD ¼ö¹ÝÇÑ ¿°Áõ¼º °Ç¼º¾È °¨º°¿¡ ´ëÇÑ ¡®TNF-¥á, IL-6, MMP-9¡¯ °Ë»çÅ°Æ®ÀÇ ¹Î°¨µµ, ƯÀ̵µ ¹× Á¤È®µµ´Â 100.00%, 34.10%, 0.670·Î MMP-9 °Ë»çÅ°Æ®º¸´Ù ´õ ³ô¾Ò´Ù.

°á·Ð : MGD Áø´Ü¿¡´Â TNF-¥á, IL-6 °Ë»ç°¡ À¯¿ëÇϸç, ¡®TNF-¥á, IL-6, MMP-9¡¯ °Ë»çÅ°Æ®´Â MGD¸¦ ¼ö¹ÝÇÑ ¿°Áõ¼º °Ç¼º¾È Æò°¡¿¡ À¯¿ëÇÒ °ÍÀ¸·Î »ç·áµÈ´Ù.

Purpose : To evaluated the ¡®TNF-¥á, IL-6, MMP-9¡¯ test kit for screening of inflammatory dry eye and IDE (inflammatory dry eye) with MGD (meibomian gland dysfunction).

Methods : A total of 118 dry eyes were selected using OSDI (ocular surface disease index) questionnaire among participated 20~30s without ophthalmologic diseases except for dry eye. Small amount of tear obtained from meniscus of the conjunctiva were tested with TNF-¥á, IL-6, and MMP-9 kit. IDE refers to the criteria which specifies the corneal staining and conjunctival hyperemia more than grade 1 and MGD refers to the criteria which specifies meibomian gland blockage and meibomian orifice obstruction with more than grade 1. Chi-square test was performed to analyze the correlation between the IDE, MGD and the results of ¡®TNF-¥á, IL-6, MMP-9¡¯ tests. and ROC (receiver operate characteristics) curve was used for the sensitivity, specificity and AUC (area under the curve) for the accuracy of ¡®TNF-¥á, IL-6, MMP-9¡¯ tests.

Results : TNF-¥á and IL-6 were significantly correlated with IDE (p£¼.050) and ¡®TNF-¥á, IL-6, MMP-9¡¯ test kit showed a high agreement of 80.20% with MMP-9 test kit(p£¼.050) although the accuracy was lower than MMP-9 test kit. The MMP-9 showed no correlation with MGD, however TNF-¥á, IL-6 were significantly correlated with MGD (p£¼.050). sensitivity, specificity, and AUC of TNF-¥á, IL-6 tests for MGD were 85.50%, 34.70%, 0.601, 85.50%, 32.70%, and 0.591. The sensitivity, specificity, and AUC of ¡®TNF-¥á, IL-6, MMP-9¡¯ test kit for IDE with MGD were 100.00%, 34.10%, and 0.670, respectively, which shows higher accuracy than MMP-9.

Conclusion : TNF-¥á and IL-6 tests are useful for the diagnosis of MGD, and ¡®TNF-¥á, IL-6, MMP-9¡¯ test kit is useful for screening IDE with MGD.

Å°¿öµå

°Ç¼º¾È; IL-6; ¿°Áõ¼º °Ç¼º¾È; ¸¶À̺½»ù±â´ÉÀúÇÏÁõ; TNF-¥á
Dry eye; IL-6; Inflammatory Dry eye; Meibomian gland disfunction; TNF-¥á

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI